Challenges and Opportunities for Typhoid Fever Control: A Call for Coordinated Action
Open Access
- 1 March 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 62 (suppl 1) , S4-S8
Abstract
The burden of enteric fever caused by Salmonella enterica serovars Typhi and Paratyphi is substantial and has high impact in toddlers and young children. This burden is relatively well documented in Asia, and this supplement provides new data on the substantial burden in several sub-Saharan African countries. Challenges in standardized surveillance and imperfect diagnostic tools have resulted in patchy local disease data, which are not well acknowledged or integrated into local country evidence and health awareness for decision making. There is a need to strengthen diagnostics for the generation of burden data in country. Furthermore, the guidelines and training for treatment of enteric fever cases in Africa are sorely needed to help mitigate the inappropriate use of antimicrobial treatment. Classic water safety and access to sanitation development remain powerful tools for the control of typhoid fever, yet the huge economic costs and long timelines are unlikely to provide a short- to middle-term solution. Emerging threats, including multidrug resistance and increasing urbanization in regions such as sub-Saharan Africa, warrant focused attention to shorter-term interventions including immunization, and must include vaccine strategies with the new typhoid conjugate vaccines.Keywords
This publication has 40 references indexed in Scilit:
- Global costs and benefits of reaching universal coverage of sanitation and drinking-water supplyJournal of Water and Health, 2012
- A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in IndiaNew England Journal of Medicine, 2009
- a study of typhoid fever in five Asian countries: disease burden and implications for controlsBulletin of the World Health Organization, 2008
- William Budd and typhoid feverJournal of the Royal Society of Medicine, 2002
- Salmonellavaccines for use in humans: present and future perspectivesFEMS Microbiology Reviews, 2002
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001
- Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunizationVaccine, 1996
- Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trialThe Lancet, 1990
- Comparative Efficacy of Two, Three, or Four Doses of TY21a Live Oral Typhoid Vaccine in Enteric-Coated Capsules: A Field Trial in an Endemic AreaThe Journal of Infectious Diseases, 1989
- Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella TyphiNew England Journal of Medicine, 1987